We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Hemspan states that it designs bio-based building systems and products for construction by combining modern methods, technology and hemp to produce net-zero carbon solutions. The company argues that every time an average house is built, the CO2 emitted by the manufacture, transport and assembly of the materials used is around 50 to 60 tonnes. Hemspan says that one hectare of UK-grown industrial hemp can absorb 11 tonnes of CO2 each year with regeneratively farmed hemp capable of sequestering a further 6 tonnes per hectare of CO2 into the soil each year. Hemspan intends to activate significant demand for hemp farming in the UK and develop processing technologies to reduce reliance on imports and enable large scale manufacturing of bio-based cladding and insulation products that spin out of R&D programmes. It asserts that the global industrial hemp market is expected to grow at 25% CAGR reaching US$ 27 billion by 2028. It aims to be a contender in this segment. 
days to go: Expired investment: £200,000
DNApal is a personalised diet, health and fitness app that combines DNA infomation with other factors like age, weight, diet, family history and health goals. Two of the largest consumer DNA companies, 23andMe and Ancestry.com, have tested over 18m people. DNApal is capable of interpreting DNA results from these companies to provide precise recommendations on how to improve diet, hormone balance, weight loss, sleep, fitness & more. The company also won the best pitch at VentureFest 2019 at Oxford Brookes University. DNApal is aiming to launch MVP in January 2020 (iOS). The company is also aiming to recommend further testing and specific supplements where necessary and offer 1:1 consultations with a specialist. With the fund raised, DNApal plans to develop the full scope of the app, weekly goals, content challenges to keep users committed.

Pitch Rated

70%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £49,990
Fighter Shots (FS) is a company that makes daily energy shots from a range of sources like ginger, turmeric and manuka honey to boost and strengthen human immunity. FS has sold over 50,000 bottles since its launch in November 2019. The functional drinks market has the potential to grow by $180 billion (11% CAGR) to $270 billion from 2020-24 on the back of COVID-19. FS aims to be a disruptor in this segment and asserts that its a dependable substitute to coffee and sugary drinks. It has secured listings with the Health Store, Tree of Life and DDC. The company is also developing sales in the United Arab Emirates (UAE). FS will use the investment to build its digital marketing and sales capabilities to bring its product to more customers.

Pitch Rated

73%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £160,000
Backed by the cutting-edge technology of Augmented Reality (AR) app, Trend Editions presents a revolutionised way of purchasing quality furniture, antiques and fabrics over the internet. It functions as a unique alternative to the traditional furniture industry. With an aim to be an AR-only UK retailer, Trend Editions has already a substantial infrastructure in place and over £150K of investment to slice their target market. Trend Editions’s high-value items are available on make-to-order basis without warehousing or showrooms.
days to go: Expired investment: £50,510
Cadello is a newly produced category-defining unique spirit produced by Distilleria Pisoni, a 150-year-old distillery in Italy. It is growing its distributors over the UK as well as Italy. The company has also partnered with Honest Grapes and other independent marketers and sales teams. Cadello has hired Italian and UK Brand Ambassadors and engaged Pegasus Spirits as UK importer and brand manager. The company will support its continued fast-paced growth by investing into its marketing and sales through tradeshows & tasting events, Brand Ambassadors, PR (editorial and events), social media & advertising, and bartending competitions.
days to go: Expired investment: £275,490
Super U is a health food brand, creating great-tasting and nutritious superfood blends and providing a natural, innovative & convenient way of consuming superfoods, without costing the Earth. The company has 3500+ online consumers and, the social audience has risen to over 8,500 followers. Additionally, Super U has been a finalist for Start-Up Business of the Year and Health & Beauty Business of the Year 2019 - for the Great British Entrepreneur Awards. The funds will be used for growth, marketing and export strategies.
days to go: Expired investment: £160,110
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph